BANK VONTOBEL/PUT/NOVO NORDISK ADR B/88/0.1/20.09.24 Share Price

Warrant

DE000VM31AJ2

Delayed Deutsche Boerse AG 12:41:59 08/05/2024 BST
0.037 EUR -5.13% Intraday chart for BANK VONTOBEL/PUT/NOVO NORDISK ADR B/88/0.1/20.09.24
Current month-32.76%
1 month-51.25%
Date Price Change Volume
08/05/24 0.037 -5.13% 0
07/05/24 0.039 -30.36% 0
06/05/24 0.056 -6.67% 0
03/05/24 0.06 0.00% 0
02/05/24 0.06 +3.45% 0

Delayed Quote Deutsche Boerse AG

Last update May 08, 2024 at 12:41 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying NOVO NORDISK A/S
IssuerLogo Issuer Vontobel Vontobel
WKN VM31AJ
ISINDE000VM31AJ2
Date issued 16/10/2023
Strike 88 $
Maturity 20/09/2024 (135 Days)
Parity 10 : 1
Emission price 0.56
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.84
Lowest since issue 0.028
Delta-0.04x
Omega 9.977
Premium31.23x
Gearing275.39x
Moneyness 0.6913
Difference Strike -40.03 $
Difference Strike %-45.48%
Spread 0.01
Spread %20.83%
Intrinsic value 0.000000

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
882.6 DKK
Average target price
908.7 DKK
Spread / Average Target
+2.95%
Consensus